Regis Radermecker

Academic Qualifications • 2012: Thesis PhD in Medical Sciences; University of Liège, Belgium • 2005: Certificate of Attendance. Course in the field of clinical trials; Oxford - UK (GCP ) • 2004: Specialist Internal Medicine; University of Liège, Belgium • 2002: Acute Medicine; University of Liège, Belgium • 1999: Doctor in Medicine, Surgery, Obstetrics; University of Liège, Belgium Current Professor of Clinical Pharmacology of Liege University, Belgium and also in co-diplomation with UNamur (Namur- Belgium), ULB (Brussels- Belgium) and UCL (Brussels-Belgium) Founder of University Certificate in Clinical Trials (Liege University, Belgium) Brief Summary of Relevant Clinical Research Exterience :  More than 15 phase 3 trials in the field of Diabetes and Metabolic Disorders ( as Principal Investigator or Co Investigator )  More than 80 national or international papers in the field of Diabetes and Metabolic Disorders (as First or Co-author)  More than 100 communications national or international conventions in the field of Diabetes and Metabolic Disorders (as First or Co-author)  More than 250 lectures for GPs and Sps  More than 50 symposia as President and/or Moderator for GPs and SPs  Reviewer for more than 15 international medical peer reviewed journals  Founder member of the Evadiac Study Group  Past Treasurer of the Belgian Lipid Club/ Belgian Athersoclerosis Society  Past Chief Editor of Belgian Association of Diabetes  Treasurer of the Liège Medico-surgical Association  Past President of the Liège Medico-surgical Association  Member of SFPT (Société Française de Pharmacologie et de Thérapeutique)  Member of Council Administration of SFD (Société Francophone du diabète)  Member of Council Administration of Belgian Association of Diabetes  General Secretary of Belgian Association of Diabetes  Member of Hospital-Academic Ethic Committee of Liege  Member of « Comité d'évaluation des pratiques médicales en matière de médicaments (CEM)-Concertation Médico-Pharmaceutique (CMP) » for RIZIV-INAMI (Federal Health department)  Mandatory diabetologist expert for federal GEES (groupe d'experts en charge de l'Exit Strategy for Covid 19 crisis)  President of « Comité Médico pharmaceutique du CHU de Liège » Google Scholar 2021: Indice H:20, Indice i10: 32 Publications: https://orbi.uliege.be